Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients

Por Okparavero, Aghogho A, Tighiouart, Hocine, Krishnasami, Zipporah, Wyatt, Christina M, Graham, Hiba, Hellinger, James, Inker, Lesley A
Publicado em 2013

Relationship between Dose, Drug Levels, and D2 Receptor Occupancy for the Atypical Antipsychotics Risperidone and Paliperidone

Por Muly, E. C., Votaw, J. R., Ritchie, J., Howell, L. L.
Publicado em 2012

Novel Strategies for Anterior Segment Ocular Drug Delivery

Por Cholkar, Kishore, Patel, Sulabh P., Vadlapudi, Aswani Dutt, Mitra, Ashim K.
Publicado em 2013

Clozapine-Related EEG Changes and Seizures: Dose and Plasma-Level Relationships

Por Varma, Seema, Bishara, Delia, Besag, Frank M. C., Taylor, David
Publicado em 2011

Analysis of pramipexole dose–response relationships in Parkinson’s disease

Por Wang, Ying, Sun, Sheng-Gang, Zhu, Sui-Qiang, Liu, Chun-Feng, Liu, Yi-Ming, Di, Qing, Shang, Hui-Fang, Ren, Yan, Xiang, Wei, Chen, Sheng-Di
Publicado no Drug Des Devel Ther (2016)

T-bet expression in rheumatoid arthritis patients with early, disease-modifying anti-rheumatic drug...

Por Ponchel, F, Brown, AK, Field, SL, Quinn, M, Conaghan, P, Emery, P, Isaacs, JD
Publicado em 2005

Novel Curcumin Derivative CNB-001 Mitigates Obesity-Associated Insulin Resistance

Por Panzhinskiy, Evgeniy, Hua, Yinan, Lapchak, Paul A., Topchiy, Elena, Lehmann, Teresa E., Ren, Jun, Nair, Sreejayan
Publicado em 2014

The γ-Secretase Modulator, BMS-932481, Modulates Aβ Peptides in the Plasma and Cerebrospinal Fluid of Healthy Volunteers

Por Soares, Holly D., Gasior, Maciej, Toyn, Jeremy H., Wang, Jun-Sheng, Hong, Quan, Berisha, Flora, Furlong, Michael T., Raybon, Joseph, Lentz, Kimberley A., Sweeney, Francis, Zheng, Naiyu, Akinsanya, Billy, Berman, Robert M., Thompson, Lorin A., Olson, Richard E., Morrison, John, Drexler, Dieter M., Macor, John E., Albright, Charlie F., Ahlijanian, Michael K., AbuTarif, Malaz
Publicado no J Pharmacol Exp Ther (2016)

Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients

Por Shin, Sooyoung, Lee, Sukhyang
Publicado em 2014

The Fate and Function of Therapeutic Antiaddiction Monoclonal Antibodies across the Reproductive Cycle of Rats

Por Hubbard, Jonathan J., Laurenzana, Elizabeth M., Williams, D. Keith, Gentry, W. Brooks, Owens, S. Michael
Publicado em 2011

Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma

Por Andrés-Guerrero, Vanessa, Perucho-González, Lucía, García-Feijoo, Julián, Morales-Fernández, Laura, Saenz-Francés, Federico, Herrero-Vanrell, Rocío, Júlvez, Luis Pablo, Llorens, Vicente Polo, Martínez-de-la-Casa, José María, Konstas, Anastasios-Georgios P.
Publicado no Adv Ther (2016)

Robust Translation of γ-Secretase Modulator Pharmacology across Preclinical Species and Human Subjects

Por Toyn, Jeremy H., Boy, Kenneth M., Raybon, Joseph, Meredith, Jere E., Robertson, Alan S., Guss, Valerie, Hoque, Nina, Sweeney, Francis, Zhuo, Xiaoliang, Clarke, Wendy, Snow, Kimberly, Denton, R. Rex, Zuev, Dmitry, Thompson, Lorin A., Morrison, John, Grace, James, Berisha, Flora, Furlong, Michael, Wang, Jun-Sheng, Lentz, Kimberly A., Padmanabha, Ramesh, Cook, Lynda, Wei, Cong, Drexler, Dieter M., Macor, John E., Albright, Charlie F., Gasior, Maciej, Olson, Richard E., Hong, Quan, Soares, Holly D., AbuTarif, Malaz, Ahlijanian, Michael K.
Publicado no J Pharmacol Exp Ther (2016)

Drug development in Alzheimer’s disease: the path to 2025

Por Cummings, Jeffrey, Aisen, Paul S., DuBois, Bruno, Frölich, Lutz, Jack, Clifford R., Jones, Roy W., Morris, John C., Raskin, Joel, Dowsett, Sherie A., Scheltens, Philip
Publicado no Alzheimers Res Ther (2016)

Variation in dose and plasma level of lamotrigine in patients discharged from a mental health trust

Por Douglas-Hall, Petrina, Dzahini, Olubanke, Gaughran, Fiona, Bile, Ahmed, Taylor, David
Publicado no Ther Adv Psychopharmacol (2016)

Effects of Diacerein at the Molecular Level in the Osteoarthritis Disease Process

Por Martel-Pelletier, Johanne, Pelletier, Jean-Pierre
Publicado em 2010

New Pyripyropene A Derivatives, Highly SOAT2-Selective Inhibitors, Improve Hypercholesterolemia and Atherosclerosis in Atherogenic Mouse Models

Por Ohshiro, Taichi, Ohtawa, Masaki, Nagamitsu, Tohru, Matsuda, Daisuke, Yagyu, Hiroaki, Davis, Matthew A., Rudel, Lawrence L., Ishibashi, Shun, Tomoda, Hiroshi
Publicado no J Pharmacol Exp Ther (2015)

Cerebrospinal Fluid Calbindin D Concentration as a Biomarker of Cerebellar Disease Progression in Niemann-Pick Type C1 Disease

Por Bradbury, Allison, Bagel, Jessica, Sampson, Maureen, Farhat, Nicole, Ding, Wenge, Swain, Gary, Prociuk, Maria, O’Donnell, Patricia, Drobatz, Kenneth, Gurda, Brittney, Wassif, Christopher, Remaley, Alan, Porter, Forbes, Vite, Charles
Publicado no J Pharmacol Exp Ther (2016)

Albumin-based drug delivery: harnessing nature to cure disease

Por Larsen, Maja Thim, Kuhlmann, Matthias, Hvam, Michael Lykke, Howard, Kenneth A.
Publicado no Mol Cell Ther (2016)

BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease

Por Vassar, Robert
Publicado no Alzheimers Res Ther (2014)

Predicting relapse of Graves' disease following treatment with antithyroid drugs

Por LIU, LIN, LU, HONGWEN, LIU, YANG, LIU, CHANGSHAN, XUN, CHU
Publicado no Exp Ther Med (2016)